Sanofi (SNY) Non-Current Debt (2009 - 2025)

Sanofi (SNY) has 17 years of Non-Current Debt data on file, last reported at $16.6 billion in Q4 2025.

• Quarterly Non-Current Debt rose 31.63% year-over-year to $16.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.6 billion (up 31.63% YoY) and the FY2025 annual result came in at $16.6 billion, up 31.63% from the prior year.
• Non-Current Debt climbed to $16.6 billion in Q4 2025 per SNY's latest filing, from $14.9 billion in the prior quarter.
• The five-year high for Non-Current Debt was $21.6 billion in Q2 2021, with the low at $12.6 billion in Q4 2024.
• Average Non-Current Debt over 5 years is $16.2 billion, with a median of $15.5 billion recorded in 2023.
• Year-over-year, Non-Current Debt slipped 22.62% in 2022 and surged 31.63% in 2025.
• Sanofi's Non-Current Debt stood at $19.6 billion in 2021, then fell by 22.62% to $15.2 billion in 2022, then grew by 1.84% to $15.4 billion in 2023, then retreated by 18.38% to $12.6 billion in 2024, then surged by 31.63% to $16.6 billion in 2025.
• Business Quant data shows SNY's Non-Current Debt at $16.6 billion in Q4 2025, $14.9 billion in Q2 2025, and $12.6 billion in Q4 2024.